Association Between Types of Carbapenemase and Clinical Outcomes of Infection Due to Carbapenem Resistance Enterobacterales

Korawan Pudpong,1,2 Sutthiporn Pattharachayakul,3 Wichai Santimaleeworagun,4,5 Ozioma F Nwabor,6 Varaporn Laohaprertthisan,7 Thanaporn Hortiwakul,6 Boonsri Charernmak,6 Sarunyou Chusri6 1Department of Pharmacy, College of Pharmacotherapy Thailand, Nontaburi, 11000, Thailand; 2Pharmaceutical Care Uni...

Full description

Bibliographic Details
Published in:	Infection and Drug Resistance
Main Authors:	Pudpong K, Pattharachayakul S, Santimaleeworagun W, Nwabor NF, Laohaprertthisan V, Hortiwakul T, Charernmak B, Chusri S
Format:	Article
Language:	English
Published:	Dove Medical Press 2022-06-01
Subjects:	carbapenemase carbapenem resistance enterobacterales ndm-1 oxa-48 ndm-1/oxa-48
Online Access:	https://www.dovepress.com/association-between-types-of-carbapenemase-and-clinical-outcomes-of-in-peer-reviewed-fulltext-article-IDR

Similar Items

Emergence and Spread of Enterobacterales with Multiple Carbapenemases after COVID-19 Pandemic
by: Branka Bedenić, et al.
Published: (2023-05-01)

Detection of rare carbapenemases in Enterobacterales—comparison of two colorimetric and three CIM-based carbapenemase assays
by: Lukas Schaffarczyk, et al.
Published: (2024-02-01)

Dissemination of OXA-48- and NDM-1-Producing Enterobacterales Isolates in an Algerian Hospital
by: Amel Abderrahim, et al.
Published: (2022-05-01)

Clinical, microbiological characteristics and predictors of mortality in patients with carbapenemase-producing Enterobacterales bloodstream infections: a multicentre study
by: Vanesa Anton-Vazquez, et al.
Published: (2023-09-01)

Genotypic Distribution and Antimicrobial Susceptibilities of Carbapenemase-Producing Enterobacteriaceae Isolated in Tertiary Care Hospital in South India
by: S. Abhishek, et al.
Published: (2022-12-01)

Investigation of Carbapenem resistance mechanisms in Klebsiella pneumoniae by using phenotypic tests and a molecular assay
by: Esra Ciftci, et al.
Published: (2019-11-01)

Meropenem MICs at Standard and High Inocula and Mutant Prevention Concentration Inter-Relations: Comparative Study with Non-Carbapenemase-Producing and OXA-48-, KPC- and NDM-Producing <i>Klebsiella pneumoniae</i>
by: Maria V. Golikova, et al.
Published: (2023-05-01)

Genotypic characterisation of carbapenemase-producing organisms obtained in Denmark from patients associated with the war in Ukraine
by: Rasmus Skjold Stolberg, et al.
Published: (2023-09-01)

Epidemiological and genetic characteristics of clinical carbapenemase-producing Enterobacterales isolates from Batna hospitals in Algeria
by: Amel Benbouza, et al.
Published: (2024-12-01)

Current trends of Carbapenemase Production Amongst Multi-drug Resistant Gram-Negative Bacteria in a Tertiary-Care Hospital in West Bengal
by: Arunima Chakravarty, et al.
Published: (2025-01-01)

Whole-genome sequence analysis of carbapenem-resistant Enterobacteriaceae recovered from hospitalized patients
by: Maria El Khoury, et al.
Published: (2023-09-01)

Investigating the relationship between carbapenemase production and biofilm formation in Klebsiella pneumoniae clinical isolates
by: Nora M. El Naggar, et al.
Published: (2024-02-01)

Ceftazidim-avibactam susceptibility of carbapenemase producing enterobacterales in an OXA-48 endemic area
by: Şevval Arduç Tok, et al.
Published: (2024-12-01)

The Synergistic Activity and Optimizing Doses of Tigecycline in Combination with Aminoglycosides against Clinical Carbapenem-Resistant <em>Klebsiella pneumoniae</em> Isolates
by: Parnrada Nulsopapon, et al.
Published: (2021-06-01)

Clinical outcomes of phenotype-guided treatment in group D carbapenemase-producing Enterobacterales bacteremia
by: Jinghao Nicholas Ngiam, et al.
Published: (2025-07-01)

Antimicrobial Activity Profiles and Potential Antimicrobial Regimens against Carbapenem-Resistant Enterobacterales Isolated from Multi-Centers in Western Thailand
by: Parnrada Nulsopapon, et al.
Published: (2022-03-01)

High prevalence of OXA-48-like and NDM carbapenemases among carbapenem resistant Klebsiella pneumoniae of clinical origin from Iran
by: Fatemeh Ghanbarinasab, et al.
Published: (2023-10-01)

Carbapenem resistance determinants and their transmissibility among clinically isolated Enterobacterales in Lebanon
by: Jennifer Moussa, et al.
Published: (2023-12-01)

Trends in carbapenem resistance in Pre-COVID and COVID times in a tertiary care hospital in North India
by: Nirupama Chatterjee, et al.
Published: (2023-01-01)

Carbapenemase producing Enterobacterales clinical isolates from a tertiary care hospital in Egypt
by: Inas El Defrawy, et al.
Published: (2023-11-01)

Tracing the transmission of carbapenem-resistant Enterobacterales at the patient: ward environmental nexus
by: Linzy Elton, et al.
Published: (2024-12-01)

Molecular detection of OXA-48 and NDM-1 carbapenemase genes among clinical isolates of Klebsiella pneumoniae recovered from patients attending a private tertiary hospital in Southwestern Nigeria
by: Chisom Blossom Onyeji, et al.
Published: (2024-09-01)

Dissemination of Carbapenemases (OXA-48, NDM and VIM) Producing <i>Enterobacteriaceae</i> Isolated from the Mohamed VI University Hospital in Marrakech, Morocco
by: Souad Loqman, et al.
Published: (2021-04-01)

Enterobacterial infection in Saudi Arabia: First record of Klebsiella pneumoniae with triple carbapenemase genes resistance
by: Mubashir Ahmad Khan, et al.
Published: (2019-04-01)

OXA-48 Carbapenemase-Producing Enterobacterales in Spanish Hospitals: An Updated Comprehensive Review on a Rising Antimicrobial Resistance
by: Mario Rivera-Izquierdo, et al.
Published: (2021-01-01)

OXA-48-like carbapenemases in Proteus mirabilis – novel genetic environments and a challenge for detection
by: Janko Sattler, et al.
Published: (2024-12-01)

Polyclonal Endemicity of Carbapenemase-Producing <i>Klebsiella pneumoniae</i> in ICUs of a Greek Tertiary Care Hospital
by: Efthymia Protonotariou, et al.
Published: (2022-01-01)

Detection of OXA-181 Carbapenemase in Shigella flexneri
by: Ghulam Dhabaan, et al.
Published: (2024-05-01)

Wide spread of OXA-48-producing Enterobacteriaceae in Algerian hospitals: A four years’ study
by: Nadjet Aggoune, et al.
Published: (2018-11-01)

Transmission of NDM-5-Producing and OXA-48-Producing Escherichia coli Sequence Type 648 by International Visitors without Previous Medical Exposure
by: Sohei Harada, et al.
Published: (2021-12-01)

Genomic Characterization of Carbapenemase-Producing <i>Enterobacter hormaechei</i>, <i>Serratia marcescens</i>, <i>Citrobacter freundii</i>, <i>Providencia stuartii</i>, and <i>Morganella morganii</i> Clinical Isolates from Bulgaria
by: Stefana Sabtcheva, et al.
Published: (2024-05-01)

Multiplex PCR Detection of Common Carbapenemase Genes and Identification of Clinically Relevant <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> Complex
by: Rujirat Hatrongjit, et al.
Published: (2022-12-01)

Molecular Characterization of Carbapenem Resistant <i>Klebsiella pneumoniae</i> in Malaysia Hospital
by: Min Yi Lau, et al.
Published: (2021-03-01)

First detection in Spain of NDM-1-producing Pseudomonas aeruginosa in two patients transferred from Ukraine to a university hospital
by: Marta Hernández-García, et al.
Published: (2024-03-01)

Rapid Screening for Carbapenem Resistant Organisms: Current Results and Future Approaches
by: Shalini Anandan, et al.
Published: (2015-09-01)

Carbapenem-Resistant Organisms Isolated in Surgical Site Infections in Benin: A Public Health Problem
by: Carine Laurence Yehouenou, et al.
Published: (2022-08-01)

Rapidly spreading Enterobacterales with OXA-48-like carbapenemases
by: Gisele Peirano, et al.
Published: (2025-02-01)

INVESTIGATION OF THE SUSCEPTIBILITY OF CARBAPENEMRESISTANT KLEBSIELLA PNEUMONIAE ISOLATES TO APRAMYCIN
by: Sevinç Baba, et al.
Published: (2022-02-01)

Genomic analysis of carbapenemase-encoding plasmids and antibiotic resistance in carbapenem-resistant Klebsiella pneumoniae isolates from Vietnam, 2021
by: Lisa Göpel, et al.
Published: (2025-05-01)

Association Between Carbapenem-Resistant Enterobacterales (CRE) Colonization Status at Time of Hospital Admission and the Subsequent Development of CRE Infection and Mortality in High-Risk Patients
by: Alraddadi BM, et al.
Published: (2024-10-01)